T
TransMedics Group, Inc.
TMDX · NASDAQ · Healthcare · 3.1B
Price · close
$94.77
+4.31% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
16.9×
Price / net assetsP/B
6.8×
Enterprise value / EBITDAEV/EBITDA
21.6×
Free cash flow yieldFCF yield
4.1%
Return on equityROE
40.2%
Operating margin
17.9%
Net debt / EBITDAbalance-sheet strength
-0.1×
Interest coverage
7.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.